USE OF SYNGENEIC MONOCLONAL-ANTIBODIES IN THE THERAPY OF DISSEMINATED MYELOID LEUKEMIC-CELLS

被引：6

作者：

BERENDS, D

MULDER, AH

VANHOUWELINGEN, G

DEBOTH, NJ

机构：

来源：

INTERNATIONAL JOURNAL OF CANCER | 1988年 / 42卷 / 01期

关键词：

D O I：

10.1002/ijc.2910420109

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：42 / 47

页数：6

共 29 条

[11]

DILLMAN RO, 1982, HYBRIDOMAS CANCER DI

[12]

DIXON WJ, 1983, BMDP STATISTICAL SOF

[13]

HERLYN D, 1985, J IMMUNOL, V134, P1300

[14]

HERLYN DM, 1980, CANCER RES, V40, P717

[15]

KENNEL SJ, 1985, CANCER RES, V45, P3782

[16]

KENNEL SJ, 1983, CANCER RES, V43, P2843

[17]

KIRCH ME, 1981, J IMMUNOL, V127, P805

[18] CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].

KOHLER, G ;

MILSTEIN, C .

NATURE, 1975, 256 (5517) :495-497

[19] STUDY OF ANTIBODIES AGAINST HUMAN MELANOMA PRODUCED BY SOMATIC-CELL HYBRIDS [J].

KOPROWSKI, H ;

STEPLEWSKI, Z ;

HERLYN, D ;

HERLYN, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (07) :3405-3409

[20] TREATMENT OF B-CELL LYMPHOMA WITH MONOCLONAL ANTI-IDIOTYPE ANTIBODY [J].

MILLER, RA ;

MALONEY, DG ;

WARNKE, R ;

LEVY, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (09) :517-522

← 1 2 3 →